GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » EV-to-EBIT

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) EV-to-EBIT : 7.19 (As of May. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Enterprise Value is E£3,730 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was E£519 Mil. Therefore, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT for today is 7.19.

The historical rank and industry rank for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT or its related term are showing as below:

CAI:RMDA' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.77   Med: 8.57   Max: 28.38
Current: 7.2

During the past 6 years, the highest EV-to-EBIT of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents was 28.38. The lowest was 5.77. And the median was 8.57.

CAI:RMDA's EV-to-EBIT is ranked better than
84.71% of 667 companies
in the Drug Manufacturers industry
Industry Median: 17.91 vs CAI:RMDA: 7.20

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Enterprise Value for the quarter that ended in Dec. 2023 was E£3,236 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was E£519 Mil. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 16.03%.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-EBIT Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-EBIT Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial 17.07 13.88 8.54 8.10 6.24

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.10 5.69 6.87 6.07 6.24

Competitive Comparison of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT falls into.



Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-EBIT Calculation

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3729.629/518.646
=7.19

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's current Enterprise Value is E£3,730 Mil.
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£519 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents  (CAI:RMDA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=518.646/3235.7865
=16.03 %

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Enterprise Value for the quarter that ended in Dec. 2023 was E£3,236 Mil.
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was E£519 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines